Eric Holmgren
Overview
Explore the profile of Eric Holmgren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
4831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Treon S, Kotton C, Park D, Moranzoni G, Lemvigh C, Gathe Jr J, et al.
Front Immunol
. 2025 Feb;
15:1369619.
PMID: 39906744
Background: Cytokine release triggered by a hyperactive immune response is thought to contribute to severe acute respiratory syndrome coronavirus 2019 (SARS-CoV-2)-related respiratory failure. Bruton tyrosine kinase (BTK) is involved in...
2.
Johnson D, Fehrenbacher L, Novotny W, Herbst R, Nemunaitis J, Jablons D, et al.
J Clin Oncol
. 2023 May;
41(13):2305-2312.
PMID: 37126944
Purpose: To investigate the efficacy and safety of bevacizumab plus carboplatin and paclitaxel in patients with advanced or recurrent non-small-cell lung cancer. Patients And Methods: In a phase II trial,...
3.
Holmgren E, Schartz D, Puttige Ramesh N, Sylvester K, Eskey C
J Oral Maxillofac Surg
. 2020 Oct;
79(2):430.e1-430.e12.
PMID: 33068533
Purpose: Penetrating facial trauma is an uncommon injury, but patients who present with these dramatic situations require special consideration. We describe the case of a young man who had been...
4.
Dreyling M, Tam C, Wang M, Smith S, Ladetto M, Huang H, et al.
Future Oncol
. 2020 Sep;
17(3):255-262.
PMID: 32985902
Mantle cell lymphoma is an aggressive B-cell malignancy. Current frontline chemoimmunotherapies produce high response rates but relapse is inevitable. Furthermore, the elderly and those with comorbidities are precluded from standard...
5.
Trotman J, Opat S, Gottlieb D, Simpson D, Marlton P, Cull G, et al.
Blood
. 2020 Jul;
136(18):2027-2037.
PMID: 32698195
Inhibitors of Bruton's tyrosine kinase (BTK) have established therapeutic activity in patients with Waldenström macroglobulinemia (WM). Zanubrutinib, a potent and selective BTK inhibitor, was evaluated in a phase 1/2 study...
6.
Hu Z, Bendell J, Bullock A, Loconte N, Hatoum H, Ritch P, et al.
Cancer Med
. 2019 Jul;
8(11):5148-5157.
PMID: 31347292
Purpose: Notch signaling dysregulation is implicated in the development of pancreatic adenocarcinoma (PDAC). Tarextumab is a fully human IgG2 antibody that inhibits Notch2/3 receptors. Patients And Methods: Aphase 2, randomized,...
7.
Holmgren E
Contemp Clin Trials
. 2017 Mar;
63:13-18.
PMID: 28245996
Using stopping boundaries developed for group sequential trials, we control the overall type 1 error for a series of tests that evaluate the treatment effect of an experimental agent in...
8.
Songen H, Marutschke C, Spijker P, Holmgren E, Hermes I, Bechstein R, et al.
Langmuir
. 2016 Dec;
33(1):125-129.
PMID: 27960056
Solid-liquid interfaces are decisive for a wide range of natural and technological processes, including fields as diverse as geochemistry and environmental science as well as catalysis and corrosion protection. Dynamic...
9.
Russell S, Blackwell K, Lawrence J, Pippen Jr J, Roe M, Wood F, et al.
J Clin Oncol
. 2010 Jun;
28(21):3416-21.
PMID: 20530275
Purpose: An independent Adjuvant Cardiac Review and Evaluation Committee (ACREC) systematically reviewed cases of symptomatic heart failure events to uniformly define the cardiac event rate across two large trials (National...
10.
Kabbinavar F, Wallace J, Holmgren E, Yi J, Cella D, Yost K, et al.
Oncologist
. 2008 Sep;
13(9):1021-9.
PMID: 18776057
Purpose: To compare the time to deterioration in health-related quality of life (HRQoL) in patients with previously untreated metastatic colorectal cancer receiving a 5-fluorouracil (5-FU)-based chemotherapy regimen with or without...